Skip to content

Hypoxia at Multiple Wavelengths of Light

Effect of Induced Hypoxia at Multiple Wavelengths

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01957891
Enrollment
26
Registered
2013-10-08
Start date
2013-09-30
Completion date
2014-02-28
Last updated
2014-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia in Healthy Individuals

Keywords

Hypoxia, Multiple wavelengths

Brief summary

The purpose of the study is to assess the effect of progressive, incremental hypoxia at multiple wavelengths of light.

Detailed description

No additional information is required.

Interventions

None listed

Sponsors

Nonin Medical, Inc
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Is between 18 and 35 years of age * Is American Society Anesthesiologist status 1 * Has a BMI between 18 and 30

Exclusion criteria

* Currently taking any medications other than birth control pills * Has participate in an investigational drug study within one month prior to the start of the study * Fails the Allen's Test to confirm patency of the colateral artery * Subject is female with a positive pregnancy test, or is female and is unwilling to use effective birth control between the time of screening and study termination * Has a positive urine continine or drug test * Has an reported allergy to Lidocaine * Has anemia or other hemoglobinopathy * Has a room air saturation less than 95% by pulse oximetry * Has an abnormal EKG * Has an abnormal pulmonary function test via spirometry * Is intolerant to a breathing mask apparatus * Has a COHb greater than 3%, or MetHb greater than 2% * Has another condition, which in the opinion of the principle investigator would not be suitable for participation in the study * Is unwilling or unable to provide informed consent or comply with the study procedures

Design outcomes

Primary

MeasureTime frame
Assess the effect of progressive, incremental hypoxia at multiple wavelengths of lightUp to 8 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026